PepGen Inc.: H.C. Wainwright Sees Nearly 250% Price Potential in Light of Significant Discount to Peers

PepGen Inc. (PEPG) is a clinical biotechnology company focused on developing next-generation oligonucleotide therapies to transform the treatment of severe neuromuscular and neurological disorders. The core business model is based on the proprietary Enhanced Delivery Oligonucleotide (EDO) platform. The enhanced delivery oligonucleotide (EDO) platform The major challenge with oligonucleotide therapies, as used in the treatment of genetic diseases, is the efficient delivery of therapeutic molecules into target cells, particularly into the nuclei...